Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: A distinct subgroup of early breast cancer patients

Breast Cancer Research and Treatment

Volumn 97, Issue 3, 2006, Pages 293-299

  Zgajnar, Janez ^a   Hocevar, Marko ^a   Podkrajsek, Maja ^a   Hertl, Kristijana ^a   Frkovic Grazio, Snjezana ^a   Vidmar, Gaj ^b   Besic, Nikola ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Breast cancer; Lymph nodes; Neoplasms; Sentinel node; Ultrasound

Indexed keywords

BLUE PATENTE V; DISULFINE BLUE; ESTROGEN RECEPTOR; NANOCOL; NANOCOLL TC 99M; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; DEVICE; EARLY CANCER; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; REGRESSION ANALYSIS; SENTINEL LYMPH NODE BIOPSY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33745353132     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9123-6     Document Type: Article

References (30)

1. Schwartz GF, Giuliano AE, Veronesi U: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94: 2542-2551, 2002
2. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349: 546-553, 2003
3. Torrenga H, Fabry H, van dS Jr., van Diest PJ, Pijpers R, Meijer S: Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol 88: 4-7, 2004
4. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS, III: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240: 462-468, 2004
5. Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, Lucas PC, Snyder ML, Chang AE, Newman LA: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98: 2307-2315, 2003
6. Sato K, Tamaki K, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H: Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsy. Am J Surg 187: 679-683, 2004
7. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 93: 630-635, 2001
8. Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR: A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol 11: 846-853, 2004
9. Bonnema J, van Geel AN, van Ooijen B, Mali SP, Tjiam SL, Henzen-Logmans SC, Schmitz PI, Wiggers T: Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 21: 270-274, 1997
10. de Kanter AY, van Eijck CH, van Geel AN, Kruijt RH, Henzen SC, Paul MA, Eggermont AM, Wiggers T: Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86: 1459-1462, 1999
11. Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes OR, Schultze Kool LJ: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39: 1068-1073, 2003
12. Podkrajsek M, Music MM, Kadivec M, Zgajnar J, Besic N, Pogacnik A, Hocevar M: Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15: 1044-1050, 2005
13. Zgajnar J, Frkovic-Grazio S, Besic N, Hocevar M, Vidergar-Kralj B, Gerljevic A, Pogacnik A: Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients-results of a large series. J Surg Oncol 85: 82-86, 2004
14. Sobin LHWC: UICC TNM Classification of Malignant tumours. (6th ed.). John Wiley and Sons, New York, 2002
15. Davies GC, Millis RR, Hayward JL: Assessment of axillary lymph node status. Ann Surg 192: 148-151, 1980
16. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983
17. Cutler SJ, Axtell LM, Schottenfeld D, Farrow JH: Clinical assessment of lymph nodes in carcinoma of the breast. Surg Gynecol Obstet 131: 41-52, 1970
18. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152: 765-772, 1981
19. Specht MC, Fey JV, Borgen PI, Cody HS, III: Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 200: 10-14, 2005
20. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS, III, Kattan MW: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: 1140-1151, 2003
21. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE: Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 40: 1731-1737, 2004
22. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, Zurrida S, Maisonneuve P, Paganelli G, Mazzarol G: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241: 319-325, 2005
23. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89: 574-581, 2000
24. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ, Carson WB, Burak WE, Jr: Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182: 316-320, 2001
25. Fisher ER, Anderson S, Redmond C, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71: 2507-2514, 1993
26. Morrow M: A survival benefit from axillary dissection: was Halsted correct? Ann Surg Oncol 6: 17-18, 1999
27. den Bakker MA, van Weeszenberg A, de Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH, Menke-Pluymers M: Nonsentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 55: 932-935, 2002
28. Nos C, Harding-MacKean C, Freneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB: Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 90: 1354-1360, 2003
29. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA: Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39: 1654-1667, 2003
30. Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Harrison R: Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7: 87-97, 2000